Sign in
4

Changes in Ownership

PRECISION BIOSCIENCES INC Filed Acc 0001209191-21-020823

President and CEO sold 9,712 shares at $11.36 ($110,328)

  • President and CEO acquired 21,514 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

KANE MATTHEW R. · President and CEO

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2021-03-12 Exercise or conversion : show line 1 in the form +21,514 $0.04 $861 1,939,180 D
2021-03-12 Sale : show line 2 in the form −9,712 $11.36 $110,328 1,929,468 D
Open-market sales · 9,712 sh · avg $11.36 · $110,328

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2021-03-12 Exercise or conversion : show line 3 in the form Employee Stock Option (Right to Buy) −21,514 129,084 D
Loading xslF345X03/doc4.xml…